Litian Vermögensrendite
Was ist das Vermögensrendite von Litian?
Vermögensrendite von Litian Group Inc. ist -172.42%
Was ist die Definition von Vermögensrendite?
Die Vermögensrendite gibt an, wie rentabel die Vermögenswerte eines Unternehmens bei der Erzielung von Einnahmen sind. Sie wird berechnet, indem das Nettoeinkommen durch die durchschnittliche Bilanzsumme geteilt wird.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Vermögensrendite von Unternehmen in Consumer Discretionary Sektor auf OTC im Vergleich zu Litian
Was macht Litian?
Litian Group Inc. engages in the renewable energy business. The company is involved in the creation of a solar farm in India. It also focuses on commercial real estate development business. The company was formerly known as Dino Energy Corporation and changed its name to Litian Group Inc. in June 2020. Litian Group Inc. is based in Calgary, Canada.
Unternehmen mit vermögensrendite ähnlich Litian
- Hepion Pharmaceuticals Inc hat Vermögensrendite von -174.30%
- Bankers Cobalt Corp hat Vermögensrendite von -174.28%
- LawFinance hat Vermögensrendite von -174.20%
- Pathway Health Corp hat Vermögensrendite von -173.40%
- Harvest Technology hat Vermögensrendite von -172.87%
- Aquarius AI hat Vermögensrendite von -172.73%
- Litian hat Vermögensrendite von -172.42%
- Tauriga Sciences hat Vermögensrendite von -172.32%
- Eskay Mining hat Vermögensrendite von -171.46%
- Supernova Metals hat Vermögensrendite von -171.01%
- Xantippe Resources hat Vermögensrendite von -170.35%
- Tff Pharmaceuticals Inc hat Vermögensrendite von -170.07%
- Applied Therapeutics hat Vermögensrendite von -170.00%